Ihuman Inc (IH) is a publicly traded education and training services business based in the US. iHuman is listed on the NYSE and traded in US dollars. Its current price of $1.74 is 2.4% up on its price a month ago ($1.7).
Both exchange rates and share prices fluctuate in real time, so the costs estimated here should be considered as a guide only. They don't factor in spreads, which can be hard to pin down. Always refer to the platform itself for availability and pricing.
Quantity of shares
| Platform | Finder score | Account fee | Min. initial deposit | Trade cost | Link |
|---|---|---|---|---|---|
 |
4.39 ★★★★★ |
£0 | $100 | £1,397.21 |
Go to siteCapital at risk
|
 |
3.75 ★★★★★ |
0.12% per year | £0 | £1,405.75 |
Go to siteCapital at risk
|
 |
4.3 ★★★★★ |
£0 | £0 | £1,397.21 |
Go to siteCapital at risk
|
 |
4.2 ★★★★★ |
£0 | £1 | £1,416.11 |
Go to siteCapital at risk
|
 |
4.34 ★★★★★ |
0% - 0.25% | £100 | N/A |
Go to siteCapital at risk
|
 |
4.1 ★★★★★ |
£0 | £0 | N/A |
Read reviewCapital at risk
|
 |
4.4 ★★★★★ |
£0 | £0 | £1,397.21 |
Read reviewCapital at risk
|
Full comparison of share dealing platforms
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including iHuman), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.
iHuman is a major part of the NYSE, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).
Only you can make the decision on the time to leap... but here's some supporting information and analysis.
Over the last 12 months, iHuman's shares have ranged in value from as little as $1.68 up to $3.779. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while iHuman's is 0.382. This would suggest that iHuman's shares are less volatile than average (for this exchange).
Historical closes compared with the last close of $1.74
| 1 week (2024-04-21) | 1.75% |
|---|---|
| 1 month (2024-03-27) | 2.35% |
| 3 months (2024-01-28) | -29.27% |
| 6 months (2023-10-26) | -34.34% |
| 1 year (2023-04-26) | -43.51% |
| 2 years (2022-04-26) | -34.83% |
| 3 years (2021-04-28) | -87.01% |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the iHuman P/E ratio, PEG ratio and EBITDA
iHuman's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 4x. In other words, iHuman shares trade at around 4x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of November 09, 2023 (20.44). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, iHuman's P/E ratio is best considered in relation to those of others within the industry or those of similar companies.
iHuman's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $170.7 million (£0.0 million).
The EBITDA is a measure of a iHuman's overall financial performance and is widely used to measure a its profitability.
To put that into context you can compare it against similar companies.
Sign up for weekly expert share tips
Join 100,000 subscribers who are notified about expert share tips. Plus a chance to win £800!
By signing up you agree to receive emails from Finder and to the privacy policy and terms & conditions.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Ever wondered how to invest in FTAL ETF? Learn more about it now and find out where you can invest in it. Compare ETF brokers to start investing today.
Ever wondered how to invest in FLGB ETF? Learn more about it now and find out where you can invest in it. Compare ETF brokers to start investing today.
Ever wondered how to invest in HUKX ETF? Learn more about it now and find out where you can invest in it. Compare ETF brokers to start investing today.
Thinking about buying shares in Flutter Entertainment? We explain how to do it and compare a range of providers who will give you access to global markets.
Sales of Reckitt Bencksier products like Dettol have risen due to coronavirus. Here’s how you can invest in Dettol, by buying Reckitt Benckiser shares.
Ever wondered how to buy shares in AT&T? We explain how and compare a range of providers that can give you access to many brands, including AT&T.
Ever wondered how to buy shares in Wincanton? We explain how and compare a range of providers that can give you access to many brands, including Wincanton.
Ever wondered how to buy shares in United Utilities? We explain how and compare a range of providers that can give you access to many brands, including United Utilities.
Find out how to buy shares in RELX, see its share prices over the last three months and check out our must-do checklist if you’re looking to invest.
Ever wondered how to buy shares in Reach? We explain how and compare a range of providers that can give you access to many brands, including Reach.